Randomized Phase II Study of Gemcitabine and S-1 Combination Therapy Versus Gemcitabine and Nanoparticle Albumin-Bound Paclitaxel Combination Therapy in Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC-GS/GA-rP2, CSGO-HBP-015)
Research Square (Research Square)